Takeda announces Access to Medicines strategy: 5 notes

The Japanese pharmaceutical company Takeda Pharmaceutical announced its new Access to Medicines strategy, which aims to increase patient access to the company's gastroenterology and oncology medications.

Here's what you need to know:

1. The Access to Medications strategy addresses various barriers patients around the world face while seeking accessible and affordable healthcare.

2. The strategy includes accelerated registration of the company's medicines, increased participation of local centers in clinical trials and establishment of early access programs.

3. The strategy focuses on countries with limited healthcare systems and unmet patient needs, in regions like Africa, Latin America and Southeast Asia.

4. Takeda Pharmaceutical is also opening a new office in Nairobi, Kenya. The company says it will use this office to establish partnerships across Sub-Saharan Africa.

5. At present, the company has established two corporate social responsibility programs: Takeda Initiative and HERhealth. Takeda Initiative supports healthcare workers in Africa through a partnership with the Global Fund and HERhealth addresses the need for women's healthcare services through a partnership with Business for Social Responsibility.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast